Senate finance leaders introduce bipartisan PBM Reform, NACDS hails move and calls for swift passage
Legislation aims to curtail harmful PBM middlemen tactics that inflate drug costs and force pharmacies to close.
Legislation aims to curtail harmful PBM middlemen tactics that inflate drug costs and force pharmacies to close.
Veteran pharmacy leader brings decades of experience to scale state-level advocacy.
NACDS urges policymakers to recognize and reimburse pharmacists' clinical services, especially in communities with decreasing healthcare access.
“It is imperative to reject the notion that voluntary ‘self-regulation’ is an acceptable alternative to enforceable reform. Self-policing by PBMs is not a solution — it is a stall.”
States focused on chronic disease and rural access should center implementation on pharmacies and pharmacists, modernizing reimbursement and scope of practice policies to ensure success.
Pharmacists ready to help Americans save more as FDA streamlines biosimilar approvals and advances interchangeability; NACDS urges Congress to finish its job on PBM reform.
There are many headwinds for the industry, starting with reimbursement pressure, but also extensive opportunities for collectively modernizing approaches to elevate the role of the pharmacist.
National study shows pharmacy-based care reduces costs while meeting employee demands for convenient healthcare access.
California is the latest state to hold PBMs accountable, help preserve access to pharmacies
“The President’s announcement reflects the reality that pharmacy benefit manager (PBM) tactics are exploding Americans’ prescription drug costs, and this action is an attempt to strike a blow against the PBMs’ manipulation and self-enrichment in the prescription drug supply chain."
Citing polling that found 97% of Americans want steps to reduce pharmacy closures, NACDS urged Congress and the Administration to reject PBM proposals and pass enforceable reforms.
The September campaign highlights members’ support of the NACDS Nourish My Health campaign.
With more than 125 patents, private-label collaborations, and global distribution, the company highlighted its role as a leader in cryotherapy during its TSE debut.
Retailers spotlight standout new products shaping the future of pharmacy and consumer goods.
“What I’ve always loved about this event is that it’s where partnerships start, where innovations emerge, and where good conversations turn into real opportunities.”